Takeda Pharmaceutical Company Limited (TAK)
USD 13.11
(-1.87%)
USD 13.11
(-1.87%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | 1209.86 Billion JPY | 22.65% |
| 2023 | 986.45 Billion JPY | 15.62% |
| 2022 | 853.16 Billion JPY | 13.17% |
| 2021 | 753.88 Billion JPY | -0.75% |
| 2020 | 759.59 Billion JPY | -23.02% |
| 2019 | 986.74 Billion JPY | 363.38% |
| 2018 | 212.94 Billion JPY | -5.9% |
| 2017 | 226.29 Billion JPY | -10.91% |
| 2016 | 254.01 Billion JPY | -3.18% |
| 2015 | 262.35 Billion JPY | 3.16% |
| 2014 | 254.32 Billion JPY | 10.8% |
| 2013 | 229.53 Billion JPY | 17.7% |
| 2012 | 195.01 Billion JPY | 42.21% |
| 2011 | 137.12 Billion JPY | -0.41% |
| 2010 | 137.69 Billion JPY | 4.59% |
| 2009 | 131.65 Billion JPY | 13.37% |
| 2008 | 116.13 Billion JPY | 10.28% |
| 2007 | 105.3 Billion JPY | 7.17% |
| 2006 | 98.25 Billion JPY | 3.91% |
| 2005 | 94.56 Billion JPY | 1.76% |
| 2004 | 92.93 Billion JPY | 3.85% |
| 2003 | 89.48 Billion JPY | -6.88% |
| 2002 | 96.09 Billion JPY | -4.31% |
| 2001 | 100.42 Billion JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 FY | 1209.86 Billion JPY | 22.65% |
| 2024 Q4 | 1209.86 Billion JPY | 3.44% |
| 2024 Q3 | 1169.64 Billion JPY | 1.19% |
| 2024 Q1 | 1083.37 Billion JPY | 5.53% |
| 2024 Q2 | 1155.86 Billion JPY | -5.51% |
| 2023 Q3 | 927.28 Billion JPY | -2.74% |
| 2023 Q2 | 953.45 Billion JPY | 2.8% |
| 2023 FY | 986.45 Billion JPY | 15.62% |
| 2023 Q1 | 927.51 Billion JPY | 8.71% |
| 2023 Q4 | 986.45 Billion JPY | 6.38% |
| 2022 Q3 | 811.32 Billion JPY | 3.55% |
| 2022 Q1 | 779.14 Billion JPY | 3.35% |
| 2022 Q2 | 783.47 Billion JPY | 0.56% |
| 2022 FY | 853.16 Billion JPY | 13.17% |
| 2022 Q4 | 853.16 Billion JPY | 5.16% |
| 2021 Q1 | 759.37 Billion JPY | -0.03% |
| 2021 FY | 753.88 Billion JPY | -0.75% |
| 2021 Q2 | 743.48 Billion JPY | -2.09% |
| 2021 Q4 | 753.88 Billion JPY | 1.97% |
| 2021 Q3 | 739.35 Billion JPY | -0.56% |
| 2020 Q2 | 840.84 Billion JPY | -6.83% |
| 2020 Q1 | 902.52 Billion JPY | -8.54% |
| 2020 Q3 | 801.34 Billion JPY | -4.7% |
| 2020 Q4 | 759.59 Billion JPY | -5.21% |
| 2020 FY | 759.59 Billion JPY | -23.02% |
| 2019 Q4 | 986.74 Billion JPY | 341.7% |
| 2019 Q2 | 233.3 Billion JPY | 5.37% |
| 2019 Q1 | 221.42 Billion JPY | 3.98% |
| 2019 FY | 986.74 Billion JPY | 363.38% |
| 2019 Q3 | 223.39 Billion JPY | -4.25% |
| 2018 Q4 | 212.94 Billion JPY | -5.4% |
| 2018 FY | 212.94 Billion JPY | -5.9% |
| 2018 Q3 | 225.1 Billion JPY | -3.93% |
| 2018 Q2 | 234.3 Billion JPY | -0.16% |
| 2018 Q1 | 234.67 Billion JPY | 3.71% |
| 2017 Q4 | 226.29 Billion JPY | 1.52% |
| 2017 Q3 | 222.91 Billion JPY | -6.31% |
| 2017 Q1 | 242.2 Billion JPY | -4.65% |
| 2017 Q2 | 237.92 Billion JPY | -1.77% |
| 2017 FY | 226.29 Billion JPY | -10.91% |
| 2016 Q2 | 274.99 Billion JPY | -0.95% |
| 2016 Q4 | 254.01 Billion JPY | -5.48% |
| 2016 FY | 254.01 Billion JPY | -3.18% |
| 2016 Q3 | 268.74 Billion JPY | -2.28% |
| 2016 Q1 | 277.62 Billion JPY | 5.82% |
| 2015 Q3 | 282.65 Billion JPY | 1.89% |
| 2015 Q1 | 267.57 Billion JPY | 5.21% |
| 2015 Q4 | 262.35 Billion JPY | -7.18% |
| 2015 Q2 | 277.41 Billion JPY | 3.68% |
| 2015 FY | 262.35 Billion JPY | 3.16% |
| 2014 Q4 | 254.32 Billion JPY | 0.97% |
| 2014 FY | 254.32 Billion JPY | 10.8% |
| 2014 Q3 | 251.89 Billion JPY | 5.6% |
| 2014 Q2 | 238.53 Billion JPY | 0.43% |
| 2014 Q1 | 237.52 Billion JPY | 3.48% |
| 2013 Q4 | 229.53 Billion JPY | 2.25% |
| 2013 FY | 229.53 Billion JPY | 17.7% |
| 2013 Q1 | 203.51 Billion JPY | 4.36% |
| 2013 Q2 | 208.43 Billion JPY | 2.42% |
| 2013 Q3 | 224.49 Billion JPY | 7.7% |
| 2012 Q3 | 209.52 Billion JPY | -13.17% |
| 2012 Q4 | 195.01 Billion JPY | -6.93% |
| 2012 FY | 195.01 Billion JPY | 42.21% |
| 2012 Q1 | 139.86 Billion JPY | 1.99% |
| 2012 Q2 | 241.3 Billion JPY | 72.54% |
| 2011 Q2 | 135.43 Billion JPY | -0.17% |
| 2011 Q3 | 135.98 Billion JPY | 0.41% |
| 2011 Q4 | 137.12 Billion JPY | 0.84% |
| 2011 FY | 137.12 Billion JPY | -0.41% |
| 2011 Q1 | 135.65 Billion JPY | -1.48% |
| 2010 Q4 | 137.69 Billion JPY | -0.77% |
| 2010 Q3 | 138.76 Billion JPY | 2.09% |
| 2010 Q2 | 135.92 Billion JPY | 0.0% |
| 2010 FY | 137.69 Billion JPY | 4.59% |
| 2009 FY | 131.65 Billion JPY | 13.37% |
| 2009 Q4 | 131.65 Billion JPY | 3.53% |
| 2009 Q3 | 127.17 Billion JPY | 0.0% |
| 2008 FY | 116.13 Billion JPY | 10.28% |
| 2007 FY | 105.3 Billion JPY | 7.17% |
| 2006 FY | 98.25 Billion JPY | 3.91% |
| 2005 FY | 94.56 Billion JPY | 1.76% |
| 2004 FY | 92.93 Billion JPY | 3.85% |
| 2003 FY | 89.48 Billion JPY | -6.88% |
| 2002 FY | 96.09 Billion JPY | -4.31% |
| 2001 FY | 100.42 Billion JPY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Amneal Pharmaceuticals, Inc. | 581.38 Million USD | -208001.53% |
| Bausch Health Companies Inc. | 1.54 Billion USD | -78259.391% |
| Catalent, Inc. | 574 Million USD | -210678.571% |
| Emergent BioSolutions Inc. | 328.9 Million USD | -367753.147% |
| Elanco Animal Health Incorporated | 1.73 Billion USD | -69633.084% |
| Perrigo Company plc | 1.14 Billion USD | -105945.14% |
| Teva Pharmaceutical Industries Limited | 4.02 Billion USD | -29988.759% |
| Zoetis Inc. | 2.56 Billion USD | -47086.778% |